B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

ABCB6

MOLECULAR TARGET

ATP binding cassette subfamily B member 6 (LAN blood group)

UniProt: Q9NP58NCBI Gene: 100582 compounds

ABCB6 (ATP binding cassette subfamily B member 6 (LAN blood group)) is targeted by 2 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting ABCB6

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1cinoxacin0.691
2Famotidine0.691

About ABCB6 as a Drug Target

ABCB6 (ATP binding cassette subfamily B member 6 (LAN blood group)) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 2 compounds with documented ABCB6 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

ABCB6 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.